Positron emission tomography (PET) studies have shown the spatial patterns of Tau tracer binding are closely linked to the patterns of neurodegeneration and the clinical presentation in AD patients (Bejanin et al., 2017; Okamura and Yanai, 2017). Here, MAPT is linked to Alzheimer disease.